Author： ŠŠkoloudíík David Báártováá Petra Herzig Roman
Publisher： Future Medicine
ISSN： 1745-509X
Source： Aging Health, Vol.5, Iss.1, 2009-02, pp. : 43-49
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pramipexole in the management of Parkinson’’s disease
By Reichmann Heinz Michael Schüüpbach Werner Martin
Aging Health, Vol. 4, Iss. 3, 2008-06 ,pp. :
Access to resources
Recommend
Tolcapone in the management of Parkinson’s disease
Aging Health, Vol. 2, Iss. 5, 2006-10 ,pp. :
Cognitive and psychiatric disturbances in Parkinson’’s disease
By Aarsland Dag Ehrt Uwe Rektorova Irena
Aging Health, Vol. 7, Iss. 1, 2011-02 ,pp. :
Rivastigmine for the treatment of Parkinson’s disease dementia
By Aarsland Dag Ehrt Uwe Gauthier Serge
Aging Health, Vol. 6, Iss. 3, 2010-06 ,pp. :
Managing sleep disorders in Parkinson’s disease
By Videnovic Aleksandar Simuni Tanya
Aging Health, Vol. 3, Iss. 1, 2007-02 ,pp. :